eMedicine Specialties > Emergency Medicine > Toxicology

Toxicity, Salicylate: Differential Diagnoses & Workup

Author: Lance W Kreplick, MD, MMM, FAAEM, FACEP, Medical Director of Hyperbaric Medicine, Fawcett Wound Management and Hyperbaric Medicine; Consulting Staff in Occupational Health and Rehabilitation, Company Care Occupational Health Services; President and Chief Executive Officer, QED Medical Solutions, LLC
Contributor Information and Disclosures

Updated: Jul 11, 2008

Differential Diagnoses

Acute Respiratory Distress Syndrome
Respiratory Distress Syndrome, Adult
Alcohol and Substance Abuse Evaluation
Schizophrenia
Alcoholic Ketoacidosis
Shock, Septic
Anxiety
Toxicity, Chlorine Gas
Asthma
Toxicity, Ethylene Glycol
Diabetic Ketoacidosis
Toxicity, Hydrocarbons
Lactic Acidosis
Toxicity, Iron
Metabolic Acidosis
Toxicity, Organophosphate and Carbamate
Pediatrics, Diabetic Ketoacidosis
Toxicity, Theophylline
Pediatrics, Meningitis and Encephalitis
Withdrawal Syndromes
Pediatrics, Respiratory Distress Syndrome
Pediatrics, Reye Syndrome
Pulmonary Embolism

Other Problems to Be Considered

Caffeine toxicity

Workup

Laboratory Studies

  • Obtain measurements of serum electrolytes, blood urea nitrogen (BUN), creatinine, calcium, magnesium, and glucose.
    • Repeat these tests at least every 12 hours until the salicylate level falls and the acid-base disturbance improves. If hemodialysis is required, testing is needed more frequently.
    • Monitor serum potassium concentrations; normal levels may be difficult to obtain during alkalinization therapy.
  • Serum salicylate level
    • If managing an acute or acute-on-chronic ingestion, repeat this test every 2 hours until the salicylate level falls.
    • If the levels increase, consider the possibility that a sustained-release preparation was ingested or that a concretion in the GI tract has formed.
    • In general, the Done nomogram (noted in numerous emergency medicine and toxicology textbooks) is not as useful in salicylate ingestions as other nomograms are in other ingestions. The Done nomogram has not been proven valid in the following instances:
      • Acute ingestions when other salicylates have been taken within the past 24 hours
      • Acute overdoses when salicylates have been ingested over several hours
      • Chronic salicylate ingestions
      • Ingestions of enteric-coated or sustained-release preparations
      • Renal failure patients
    • Many toxicologists suggest avoiding the use of the Done nomogram. The Done nomogram assumes complete absorption by 6 hours postingestion; 6-hour postingestion levels may be correlated with the following degrees of toxicity:
      • Less than 50 mg/dL - Asymptomatic
      • 51-110 mg/dL - Mild-to-moderate toxicity
      • 110-120 mg/dL - Severe toxicity
    • Serum levels determined less than 6 hours postingestion (acute overdose) do not rule out impending toxicity because salicylates are in the absorption-distribution phase. Likewise, in cases of chronic salicylism, measured toxic levels may be only 30-40 mg/d.
  • Urinalysis
    • Monitor and maintain an alkaline urine pH every 2 hours during alkalinization therapy.
    • Maintain a urine pH of 7.5-8 (monitor the serum pH rather than the urine pH). Excessive sodium bicarbonate induces severe alkalemia and/or hypernatremia. Consider obtaining a urine specimen for a qualitative toxicology screen.
  • Obtain hepatic, hematologic, and coagulation profiles for patients with clinical evidence of moderate-to-severe toxicity (eg, those that need to be admitted for inpatient care).
  • Arterial blood gas
    • Repeat approximately every 2 hours until metabolic acidosis improves.
    • During urinary alkalinization therapy, the arterial pH should remain between 7.3 and 7.5.

Imaging Studies

  • A chest x-ray is indicated if evidence of severe intoxication, pulmonary edema, or hypoxemia is present.
  • Consider an abdominal x-ray if an aspirin concretion is suspected. For better sensitivity, this should be performed before administration of activated charcoal.
  • Other methods of identifying gastric salicylate pharmacobezoars include the following:
    • Ultrasonography
    • CT scan of the head
    • Endoscopy

Other Tests

  • ECG
  • The ferric chloride test and the Ames Phenistix test are sensitive but nonspecific screening tests that may be available in the ED. However, these tests are currently almost never performed because of the availability of rapid and accurate quantitative serum assays.
    • If acetylsalicylic acid is present, combining 1 mL of urine and a few drops of 10% ferric chloride causes a purple color change.
    • The Phenistix turns brown if salicylates are present in the urine, but this test lacks specificity.

More on Toxicity, Salicylate

Overview: Toxicity, Salicylate
Differential Diagnoses & Workup: Toxicity, Salicylate
Treatment & Medication: Toxicity, Salicylate
Follow-up: Toxicity, Salicylate
References

References

  1. Acetylsalicylic Acid. National Library of Medicine, TOXNET, Hazardous Substances Data Bank. Available at http://toxnet.nlm.nih.gov/cgi-bin/sis/search/f?./temp/~yiK5GU:1.

  2. Brenner BE, Simon RR. Management of salicylate intoxication. Drugs. Oct 1982;24(4):335-40. [Medline].

  3. Chan TY, Chan AY, Ho CS, Critchley JA. The clinical value of screening for salicylates in acute poisoning. Vet Hum Toxicol. Feb 1995;37(1):37-8. [Medline].

  4. Chapman BJ, Proudfoot AT. Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations. Q J Med. Aug 1989;72(268):699-707. [Medline].

  5. Chiaretti A, Schembri Wismayer D, Tortorolo L, et al. Salicylate intoxication using a skin ointment. Acta Paediatr. Mar 1997;86(3):330-1. [Medline].

  6. Danel V, Henry JA, Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. Br Med J (Clin Res Ed). May 28 1988;296(6635):1507. [Medline].

  7. Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J. May 2002;19(3):206-9. [Medline].

  8. Done AK, Temple AR. Treatment of salicylate poisoning. Mod Treat. Aug 1971;8(3):528-51. [Medline].

  9. Dugandzic RM, Tierney MG, Dickinson GE, et al. Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication. Ann Emerg Med. Nov 1989;18(11):1186-90. [Medline].

  10. Gabow PA, Anderson RJ, Potts DE, Schrier RW. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med. Oct 1978;138(10):1481-4. [Medline].

  11. Gilman AG, Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 6th ed. New York: McGraw-Hill; 1980.

  12. Gittelman DK. Chronic salicylate intoxication. South Med J. Jun 1993;86(6):683-5. [Medline].

  13. Johnson D, Eppler J, Giesbrecht E, Verjee Z, Rais A, Wiggins T. Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model. Ann Emerg Med. Nov 1995;26(5):569-74. [Medline].

  14. Krause DS, Wolf BA, Shaw LM. Acute aspirin overdose: mechanisms of toxicity. Ther Drug Monit. Dec 1992;14(6):441-51. [Medline].

  15. O'Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. May 2007;25(2):333-46; abstract viii. [Medline].

  16. Proudfoot AT. Toxicity of salicylates. Am J Med. Nov 14 1983;75(5A):99-103. [Medline].

  17. Teece S, Crawford I. Best evidence topic report. Gastric lavage in aspirin and non-steroidal anti-inflammatory drug overdose. Emerg Med J. Sep 2004;21(5):591-2. [Medline].

  18. Temple AR. Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med. Feb 23 1981;141(3 Spec No):364-9. [Medline].

Further Reading

Keywords

aspirin overdose, aspirin, aspirin poisoning, aspirin ingestion, salicylate toxicity, salicylate ingestion, salicylate overdose, salicylate poisoning

Contributor Information and Disclosures

Author

Lance W Kreplick, MD, MMM, FAAEM, FACEP, Medical Director of Hyperbaric Medicine, Fawcett Wound Management and Hyperbaric Medicine; Consulting Staff in Occupational Health and Rehabilitation, Company Care Occupational Health Services; President and Chief Executive Officer, QED Medical Solutions, LLC
Lance W Kreplick, MD, MMM, FAAEM, FACEP is a member of the following medical societies: American Academy of Emergency Medicine and American College of Physician Executives
Disclosure: Nothing to disclose.

Medical Editor

Mark S Slabinski, MD, FACEP, FAAEM, Vice President, EMP Medical Group
Mark S Slabinski, MD, FACEP, FAAEM is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, and Ohio State Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

John T VanDeVoort, PharmD, ABAT, Director of Pharmacy, Sacred Heart Hospital
John T VanDeVoort, PharmD, ABAT is a member of the following medical societies: American Academy of Clinical Toxicology and American Society of Health-System Pharmacists
Disclosure: Nothing to disclose.

Managing Editor

Fred Harchelroad, MD, FACMT, Chair, Department of Emergency Medicine, Director of Medical Toxicology, Department of Emergency Medicine, Associate Professor, Allegheny General Hospital
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD, Assistant Professor, Department of Surgery, Section of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.